![shutterstock_95463775](https://www.nationalelfservice.net/cms/wp-content/uploads/2014/11/shutterstock_95463775-150x150.jpg)
Helge Hasselmann highlights a recent systematic review of anti-inflammatory drugs for depression, which concludes that NSAIDs, in particular celecoxib, decreases depressive symptoms without increased risk of adverse effects. However, the meta-analysis has a number of draw-backs, which make the study findings far from convincing.
[read the full story...]